Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 12/20 | 0.58 |
| ▸ | TLR7 | Q9NYK1 | 6/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | CASP7 | P55210 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28203089 | 1.00 | TLR8 (0.58) | TLR8TLR7LMNATSHRKDM4E | |
| SCHEMBL22498767 | 1.00 | TLR8 (0.58) | TLR8TLR7LMNATSHRKDM4E | |
| SCHEMBL1458588 | 0.98 | TLR8 (0.57) | TLR8TLR7LMNATSHRATM | |
| SCHEMBL28504818 | 0.92 | TLR8 (0.51) | TLR8TLR7LMNATSHRKDM4E | |
| SCHEMBL28510573 | 0.89 | TLR8 (0.54) | TLR8TLR7LMNATSHR | |
| SCHEMBL28508187 | 0.89 | TLR8 (0.48) | TLR8TLR7LMNATSHRKDM4E | |
| SCHEMBL28229720 | 0.87 | KDM4E (0.55) | TLR8TLR7KDM4EALDH1A1GAA | |
| SCHEMBL28503550 | 0.87 | TLR8 (0.54) | TLR8TLR7LMNACYP3A4MAPT | |
| SCHEMBL28906706 | 0.84 | TLR8 (0.54) | TLR8TLR7LMNACYP3A4MAPT | |
| SCHEMBL27871640 | 0.83 | TLR8 (0.52) | TLR8LMNATSHRKDM4EUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250352653-A1 | NEURON TARGETED 2-DEOXYGLUCOSE DENDRIMER FOR IMAGING AND TREATMENT OF NEUROLOGICAL DISEASES | UNIV WASHINGTON STATE (US) | 2025-11-20 | — | — | US | claimed |
| US-20250144078-A1 | THIOSTREPTON-INSPIRED COMPOUNDS FOR TREATMENT OF CANCER AND PREPARATION THEREOF | SYMERES NETHERLANDS B.V. (NL) | 2025-05-08 | — | — | US | claimed |
| WO-2025058566-A1 | ORALLY-DELIVERED PLATINUM PRO-DRUG AGAINST CISPLATIN-RESISTANT OVARIAN CANCER | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2025-03-20 | — | — | WO | claimed |
| CN-119301105-A | Thiostrepton-based compounds for the treatment of cancer and preparation thereof | RS肿瘤学有限责任公司 | 2025-01-10 | — | — | CN | claimed |
| US-20250011316-A1 | PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2025-01-09 | — | — | US | claimed |
| CN-116585233-B | Chinese rose flower extract and preparation method and application thereof | 浙江大学 | 2025-01-07 | — | — | CN | claimed |
| EP-4479390-A2 | THIOSTREPTON-INSPIRED COMPOUNDS FOR TREATMENT OF CANCER AND PREPARATION THEREOF | RS Oncology, LLC (US) | 2024-12-25 | — | — | EP | claimed |
| CN-114574525-B | Transport carrier for intracellular targeted mitochondria and application thereof | 中国科学院大连化学物理研究所 | 2024-06-11 | — | — | CN | claimed |
| WO-2023158679-A2 | THIOSTREPTON-INSPIRED COMPOUNDS FOR TREATMENT OF CANCER AND PREPARATION THEREOF | RS ONCOLOGY, LLC (US) | 2023-08-24 | — | — | WO | claimed |
| CN-114574525-A | Transport carrier for intracellular targeting mitochondria and application thereof | 中国科学院大连化学物理研究所 | 2022-06-03 | — | — | CN | claimed |
| WO-2022065938-A1 | COMPOUND FOR AGGREGATION-INDUCED EMISSION, COMPOSITION FOR CELL IMAGING USING SAME, AND USE AS CELL-IMAGING CONTRAST AGENT | 아주대학교산학협력단 | 2022-03-31 | — | — | WO | claimed |
| CN-122075727-A | Subcellular targeting drug delivery conjugate, preparation method, composition and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| US-12635689-B2 | Antifungal compositions | UNIVERSITY OF EXETER (GB) | 2026-05-26 | — | — | US | disclosed |
| EP-4665373-A2 | SELECT THIOSTREPTON-INSPIRED COMPOUNDS FOR TREATMENT OF CANCER AND PREPARATION THEREOF | RS Oncology, LLC (US) | 2025-12-24 | — | — | EP | disclosed |
| US-20250381278-A1 | PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER | UNIV WAKE FOREST HEALTH SCIENCES (US) | 2025-12-18 | — | — | US | disclosed |
| CN-115177734-A | Engineered exosome for targeted intervention of mitochondrial gene expression and construction method and application thereof | 中国人民解放军空军军医大学 | 2022-10-14 | — | — | CN | disclosed |
| US-20220174950-A1 | Antifungal Compositions | UNIVERSITY OF EXETER (GB) | 2022-06-09 | — | — | US | disclosed |
| WO-2022115443-A1 | MITOCHONDRIA TARGETING QUINOLINIUM-DRUG CONJUGATES AND THEIR SELF-ASSEMBLING NANOFORMULATIONS FOR CANCER THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-06-02 | — | — | WO | disclosed |
| WO-2022065938-A1 | COMPOUND FOR AGGREGATION-INDUCED EMISSION, COMPOSITION FOR CELL IMAGING USING SAME, AND USE AS CELL-IMAGING CONTRAST AGENT | 아주대학교산학협력단 | 2022-03-31 | — | — | WO | disclosed |
| EP-3945818-A1 | ANTIFUNGAL COMPOSITIONS | University of Exeter (GB) | 2022-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220174950-A1 | Antifungal Compositions | ERG28, MAPRE2, MRPS22 | TLR8 3358/4885TLR7 1625/4885LMNA 2498/4885 |
| US-12635689-B2 | Antifungal compositions | ERG28, CASP2, SRMS | TLR8 2621/4885TLR7 1676/4885LMNA 3492/4885 |
| US-20250011316-A1 | PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER | PRDX1, PRDX2, PRDX6 | TLR8 4311/4885TLR7 3115/4885LMNA 2798/4885 |
| US-20250144078-A1 | THIOSTREPTON-INSPIRED COMPOUNDS FOR TREATMENT OF CANCER AND PREPARATION THEREOF | TYMS, TOP1, TOP2A | TLR8 2601/4885TLR7 1693/4885LMNA 4577/4885 |
| US-20250381278-A1 | PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER | PRDX1, PRDX2, PRDX6 | TLR8 4212/4885TLR7 3030/4885LMNA 2786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.